Advaxis Inc logo

Advaxis Inc

$ 1.66 -0.015 (-0.9%) 10:08 PM EST
P/E:
At Loss
P/B:
0.11
Market Cap:
$ 3.00M
Enterprise V:
$ -25.13M
Volume:
239.00
Avg Vol (2M):
2.73K
Also Trade In:
Volume:
239.00
Market Cap $:
3.00M
PE Ratio:
At Loss
Avg Vol (2-Month):
2.73K
Enterprise Value $:
-25.13M
PB Ratio:
0.11
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Advaxis Inc is a clinical-stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate-Specific Antigen (PSA) associated with prostate cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 1481.58
Equity-to-Asset 0.94
Interest Coverage No Debt
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -19.98
Distress
Grey
Safe
Beneish M-Score -4.9
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 40.58
9-Day RSI 43.24
14-Day RSI 43.79
6-1 Month Momentum % -67.84
12-1 Month Momentum % -93.28

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 15.64
Quick Ratio 15.64
Cash Ratio 14.77
Days Sales Outstanding 2007.5

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -215.5

Financials (Next Earnings Date:2023-02-14 Est.)

ADXS's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with OTCPK:ADXS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.25
EPS (TTM) ($) -9.09
Beta 1.32
Volatility % 75.88
14-Day RSI 43.79
14-Day ATR ($) 0.180604
20-Day SMA ($) 1.782775
12-1 Month Momentum % -93.28
52-Week Range ($) 1.55 - 30.56
Shares Outstanding (Mil) 1.82

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Advaxis Inc Filings

Document Form Filing Date
No Filing Data

Advaxis Inc Analysis

Share your research

Headlines

See More
No news.